Cytokeratin immunoreactivity of intestinal metaplasia at normal oesophagogastric junction indicates its aetiology
about
Barrett's oesophagus: from metaplasia to dysplasia and cancerThe utility of cytokeratins 7 and 20 (CK7/20) immunohistochemistry in the distinction of short-segment Barrett esophagus from gastric intestinal metaplasia: Is it reliable?Cytokeratins in gastroenterology. Systematic reviewExpression of cytokeratins in Helicobacter pylori-associated chronic gastritis of adult patients infected with cagA+ strains: an immunohistochemical studyInflammation and cytokeratin 7/20 staining of cardiac mucosa in young patients with and without Helicobacter pylori infectionDifferences in genetic instability and cellular phenotype among Barrett's, cardiac, and gastric intestinal metaplasia in a Japanese population with Helicobacter pylori.The interplay between Helicobacter pylori, gastro-oesophageal reflux disease, and intestinal metaplasia.Unraveling the mystery of the gastroesophageal junction: a pathologist's perspective.Barrett's oesophagus--a pathologist's view.The biological meaning of intestinal metaplasia of the gastroesophageal junction.Mechanisms of Barrett's oesophagus: intestinal differentiation, stem cells, and tissue models.One year treatment of Barrett's oesophagus with proton pump inhibitors (a multi-center study).Distinction between short-segment Barrett's esophageal and cardiac intestinal metaplasia.Cytokeratin and DAS-1 immunostaining reveal similarities among cardiac mucosa, CIM, and Barrett's esophagus.Cytokeratin 7 and 20 expression in intestinal metaplasia of the distal oesophagus: relationship to gastro-oesophageal reflux disease.Identical cytokeratin expression pattern CK7+/CK20- in esophageal and cardiac cancer: etiopathological and clinical implications.Comparison of intestinal metaplasia in gastric cardia and Barrett's esophagus.Crystal violet chromoendoscopy with mucosal pit pattern diagnosis is useful for surveillance of short-segment Barrett's esophagus.Analysis of cancer marker in tissues with Hadamard transform fluorescence spectral microscopic imaging.
P2860
Q24685867-0DBD78D6-300B-4B00-8C2F-E8D8A8E368BFQ24802332-E25140E7-EEAA-4A55-A779-232C9BEF5C92Q26777674-2380C2CE-3B5D-43BF-898B-DC8939E5E783Q33866570-CA7C3251-8812-46A9-A7E1-22DEBD8FF84BQ35588464-DBA686F2-A93A-4C45-87F8-5E082555F9E5Q35691577-B2B1613A-C215-41BE-B7CE-7D0976F9E418Q36041651-223A60EA-40F8-40DA-ADEB-49B6EFD8F179Q36249717-FD6CD458-09E3-4987-B209-7FBB98B73B48Q36699514-C46E3222-B89F-4427-BA6B-F06081AC9597Q37756366-9EF1B341-27D0-4C01-9F5E-C765DC15AEB5Q38368079-FF3CB92A-AE84-451B-8AB2-688696197FCFQ39194800-1B120E37-1D1D-4F38-BF89-A6705630C1EBQ43136875-7D5DD175-375C-4913-A342-EE9A175E5A6AQ44183470-7FC48B69-1EBC-40FC-AE5E-8D3210C3BD25Q44417833-3CEDE1A0-557E-434F-BCA4-05CD561A5EDFQ44664416-5A95F309-707B-49FA-875A-39A728435313Q50436525-125B2EBA-2C87-4FB1-8CCB-68A8412B1BB2Q50486638-DCD1E3B7-9880-4F2A-83D4-B7BD95FAE500Q53318118-27384B74-B604-49A9-B3A5-E13D63ED0F39
P2860
Cytokeratin immunoreactivity of intestinal metaplasia at normal oesophagogastric junction indicates its aetiology
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Cytokeratin immunoreactivity o ...... nction indicates its aetiology
@ast
Cytokeratin immunoreactivity o ...... nction indicates its aetiology
@en
Cytokeratin immunoreactivity o ...... nction indicates its aetiology
@nl
type
label
Cytokeratin immunoreactivity o ...... nction indicates its aetiology
@ast
Cytokeratin immunoreactivity o ...... nction indicates its aetiology
@en
Cytokeratin immunoreactivity o ...... nction indicates its aetiology
@nl
prefLabel
Cytokeratin immunoreactivity o ...... nction indicates its aetiology
@ast
Cytokeratin immunoreactivity o ...... nction indicates its aetiology
@en
Cytokeratin immunoreactivity o ...... nction indicates its aetiology
@nl
P2093
P2860
P356
P1433
P1476
Cytokeratin immunoreactivity o ...... nction indicates its aetiology
@en
P2093
A Couvelard
A Rotenberg
D Goldfain
J F Fléjou
J M Cauvin
M Robaszkiewicz
P2860
P356
10.1136/GUT.49.6.761
P407
P577
2001-12-01T00:00:00Z